OraSure Technologies (OSUR) Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization
Go back to OraSure Technologies (OSUR) Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use AuthorizationOraSure Technologies, Inc. (NASDAQ: OSUR) | Delayed: 6.14 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $6.14 | 52 Week High | $9.05 | |||
Open | $6.14 | 52 Week Low | $5.10 | |||
Day High | $6.14 | P/E | N/A | |||
Day Low | $6.14 | EPS | $-0.20 | |||
Volume | 94 |